“In the state of Tennessee, marijuana is the number one drug associated with criminal activity, including violent crime.” By Adam Friedman, Tennessee Lookout ​Tennessee lawmakers held hearings to discuss implementing a limited medical marijuana program, but the state’s top law enforcement group remains the most vocal opposition. Representatives from the Tennessee Bureau of Investigation, TBI, emerged as the strongest opponents, stating there were no circumstances in which they thought medical marijuana should be allowed in Tennessee. “Marijuana is in fact a dangerous drug, whose use poses a significant threat to public safety, and whose cultivation poses a threat to the environment,” said Erica Stephens, a TBI agent working on the bureau’s Dangerous Drugs Task Force, to lawmakers during the hearing.

The Drug Enforcement Administration (DEA) has launched new specialized registration forms for additional types of state-licensed medical marijuana businesses beyond dispensaries that want to take advantage of federal protections in line with the Trump administration’s cannabis rescheduling process. The agency began accepting registrations from medical cannabis dispensaries with a new form in April, and other types of businesses in the state-legal medical marijuana supply chain have been able to apply using a standardized federal form for months. But now, DEA now has specific registration links for medical marijuana manufacturers, distributors and analytical labs…

"Continuing down the path of aggressive and over-punitive immigration policies poses a direct threat to the future of this industry." By Ishaq Ali, Latino Cannabis Alliance Behind the sleek tech-adjacent branding and modern marketing of today's cannabis industry lies a far older, unvarnished truth: cannabis is, at its heart, an agricultural product and Latinos are the majority of the agricultural labor, making up a staggering 92 percent of California’s overall agricultural workforce and 77 percent of the U.S. agricultural workforce. The cannabis industry mirrors this demographic reality; Latinos are the largest ethnic group of workers in the legally regulated cannabis sector at 38 percent, a figure that surges to 56–65 percent in cultivation-specific roles.

A coalition of anti-marijuana groups and a cannabis-focused biopharmaceutical corporation have filed a new brief in their lawsuit challenging the Trump administration's initiative to cover up to $500 worth of hemp-derived products each year for eligible Medicare patients. In May, Judge Trevor N. McFadden dismissed the challenge to the Centers for Medicare & Medicaid Services (CMS) program that focuses largely on CBD but also allows a certain amount of THC in products. The opponents of the CBD Medicare effort then asked the U.S. Court of Appeals for the District of Columbia Circuit…

A Democratic congresswoman from Massachusetts is urging voters to defeat an initiative on the November ballot that would roll back the state's marijuana legalization law. “Cannabis legalization and regulation is positive for small businesses, local communities and restorative justice," Rep. Ayanna Pressley (D-MA) said on Tuesday. "And keeping marijuana legal in Massachusetts is both economic justice and racial justice policy." "With Black, Hispanic, and other marginalized communities disproportionately ravaged by the War on Drugs, legalizing adult-use cannabis in Massachusetts was designed in part to begin addressing that legacy, through social equity programs, economic opportunities and investments in communities harmed by prohibition," she said.

Fed marijuana tax guidance a "priority"; MA gov urges voters to keep cannabis sales legal; FDA ibogaine RFI; VA FOIA docs & cannabis use disorder oped Subscribe to receive Marijuana Moment’s newsletter in your inbox every weekday morning. It’s the best way to make sure you know which cannabis stories are shaping the day. Your support makes Marijuana Moment possible… Free to read (but not free to produce)! We're proud of our newsletter and the reporting we publish at Marijuana Moment, and we're happy to provide it for free. But it takes a lot of work and resources to make this happen.

"What emerges is not simply a story of rising diagnoses, but a deeper set of concerns about how those diagnoses are defined, applied and ultimately used to shape both policy and perception." By Nate Landau, Veterans Action Council The number of cannabis use disorder (CUD) diagnoses among veterans has risen substantially within the Department of Veterans Affairs (VA), but newly released VA records obtained via the Freedom of Information Act (FOIA) raise questions about what that increase actually means. The data spans a period in which the diagnostic definition of CUD changed significantly, including VA's transition from the Diagnostic and Statistical Manual of Mental Disorders (DSM)-IV to DSM-5, making it difficult to determine how much of the recorded increase reflects actual changes in cannabis use among veterans and how much merely reflects changes in how CUD is defined, identified and coded.

The governor of Massachusetts opposes an initiative on the November ballot that would roll back the state's marijuana legalization law. “I'd vote no," Gov. Maura Healey (D) said in an interview on WCVB-TV's On The Record on Sunday. "We've got to keep recreational marijuana here in Massachusetts." "It's an important industry, the cannabis industry," the governor said. "And I hope the voters keep cannabis." A new poll released last week shows that most Massachusetts voters oppose the ballot measure to roll back marijuana legalization, in line with the governor's views.

Marijuana can have a number of effects on people who use it but there are no known instances of someone fatally overdosing from consuming cannabis, federal officials say. "No deaths from overdose of marijuana have been reported," the Drug Enforcement Administration (DEA) said in a new update to its "Drugs of Abuse" publication for 2026. That said, the agency is cautioning that cannabis's effects on perception and coordination can cause "serious impairments in learning, associative processes, and psychomotor behavior (driving abilities)" and that long-term use can lead to "physical dependence and withdrawal following discontinuation, as well as psychological addiction or dependence."

The Food and Drug Administration (FDA) is seeking public input on how to design research on the potential therapeutic benefits of the psychedelic ibogaine. The agency's request for information (RFI), released on Monday, seeks comments and data in four main areas: General study design, including appropriate patient populations; Dose selection and escalation, including the proposed use of small, sequential dose-ascending groups and a starting dose justified by available data and not exceeding 10 mg/kg; Safety considerations, including monitoring for cardiac and neurologic adverse events and other safeguards for clinical trials; and…

Federal officials say they will prioritize issuing tax-related guidance for marijuana businesses within the next year in light of the Trump administration's move to federally reschedule cannabis. Moving marijuana from Schedule I of the Controlled Substances Act (CSA) to Schedule III will have large tax implications for cannabis industry operators. That's because an Internal Revenue Service (IRS) code known as 280E, which has prevented them from taking ordinary tax deductions and credits that are available to most businesses, only applies to Schedule I and II substances. The U.S. Department of the Treasury and IRS said in April that they plan to…

NY hits $4 billion in marijuana sales; VA medical cannabis patient survey; Study: Medical marijuana for autism; NC public cannabis use policy Subscribe to receive Marijuana Moment’s newsletter in your inbox every weekday morning. It’s the best way to make sure you know which cannabis stories are shaping the day. Your support makes Marijuana Moment possible… Hold on, just one second before you read today's news. Have you thought about giving some financial support to Marijuana Moment? If so, today would be a great day to contribute. We're planning our reporting for the coming months and it would really help to know what kind of support we can count on.

"The most important protection for Missouri’s newest cannabis entrepreneurs may not be another rule. It may be knowing when not to sign." By Adrian A. Holguin, CannaShark Consulting via Missouri Independent Missouri drew its final round of marijuana microbusiness applicants on September 9. The state received 888 applications and expects to issue approximately 77 licenses beginning in December. I want to write about the months in between, because I work in the trade that operates in them. I am a consultant. I run licensing, compliance and operations work for cannabis operators, and I have sat across the table from first-time licensees more times than I can count.

"The CBD products that people are expecting to be available to give to their dogs for arthritis or to give to their parents because they’re aging and have aches...they’re not going to have access to them anymore." By Mia Maldonado, Oregon Capital Chronicle Pet tinctures and topicals are the most popular products sold at Oregon CBD Company, a small business located at the junction of the Willamette Valley town’s busiest roads. Pet owners use them to treat their pets’ anxiety or pain—and in some cases they use similar products to treat their own.

“We want the public to understand exactly what this means. We don’t want to have to have law enforcement try to guess at businesses, are they public or are they private?” By Clayton Henkel, NC Newsline North Carolina’s Advisory Council on Cannabis faces a December 31 deadline to issue final recommendations for a comprehensive cannabis policy to Gov. Josh Stein (D). While the legislature would have to agree to enact any changes in existing law, the council gave the public its first glimpse this week of how a public consumption policy might be crafted.

New York's recreational marijuana dispensaries have now sold more than $4 billion worth of legal cannabis products, state officials have announced. The Office of Cannabis Management (OCM) revealed the sales totals at a Cannabis Control Board (CCB) meeting on Thursday. The $4.1 billion worth of adult-use marijuana products since sales began in late 2022 includes almost $1.5 billion so far in 2026 alone. Third quarter sales reached $512.6 million, bringing the total for this year to date to $1.41 billion. The OCM update also noted that a significant share of the state's legal cannabis market is comprised of social and economic equity businesses, and that almost two-thirds (64 percent) of new licenses issued at Thursday's meeting meet that designation.

Florida activists submitted two new proposed marijuana legalization ballot initiatives to state officials this week. The first measure, from a group called Floridians for Marijuana, would allow adults over the age of 21 to legally use cannabis. They could possess up to two ounces of marijuana, including no more than five grams of cannabis concentrates. Existing medical cannabis dispensaries would be able to sell recreational marijuana to adults as of the effective date, which would be six months after approval by voters. New businesses would also be allowed to acquire, cultivate, process, transport and or sell marijuana to adults for personal use.

Virginia regulators are asking patients to complete a "satisfaction survey" about the state's medical marijuana program. The Virginia Cannabis Control Authority (CCA) said the questionnaire is designed to help officials "hear from the people who know Virginia’s medical cannabis program firsthand." The survey includes questions about how often patients use medical marijuana, what types of products they consume and where they obtain it from—including whether they go to retailers in other states. Responses will help CCA have a "better understanding of the patient experience and help identify opportunities to strengthen the program," the agency said, noting that last year more than 114,000 individual patients purchased medical cannabis from a licensed dispensary in Virginia.

Medical marijuana helps people with autism ease their anxiety and depression, according a new study conducted by state officials in Minnesota. The research, which involved 1,800 patients enrolled in the state's medical marijuana program, is "one of the largest on record involving autism spectrum disorder (ASD) and medical cannabis patients," officials said. Of the 88 percent of patients who reported experiencing moderate to severe anxiety upon entering the program, more than half (57 percent) were able to reduce their anxiety by 30 percent or more within four months of beginning medical cannabis use, and 67 percent of those maintained that reduction for an additional four months, according to their answers on self-report surveys.

Congressional psychedelics report; GA medical marijuana delivery; CA gov signs cannabis edibles & drinks bill; Vets medical marijuana research measure Subscribe to receive Marijuana Moment’s newsletter in your inbox every weekday morning. It’s the best way to make sure you know which cannabis stories are shaping the day. Your support makes Marijuana Moment possible… BREAKING: Journalism is often consumed for free, but costs money to produce! While this newsletter is proudly sent without cost to you, our ability to send it each day depends on the financial support of readers who can afford to give it.

Bipartisan congressional lawmakers introduced a bill to direct the U.S. Department of Veterans Affairs (VA) to carry out studies on the therapeutic potential of marijuana for military veterans with certain conditions. An earlier Senate version of the VA medical cannabis legislation cleared a committee in that chamber and was taken up on the floor for action but was blocked from advancing by Republicans. Under the proposal as reintroduced for the current Congress on Thursday by Reps. Lou Correa (D-CA) and Jack Bergman (R-MI), VA would be tasked with conducting studies that explore the effects of cannabis for veterans with post-traumatic stress disorder (PTSD) and chronic pain.

A new Maryland law that took effect this week will protect firefighters and rescue workers from being penalized over their lawful use of medical marijuana off the job. Gov. Wes Moore (D) gave final approval to the measure in April after it cleared the Senate and House of Delegates, and it officially became operative on Thursday. The new policy, which was sponsored by Sen. Carl Jackson (D), amends the state's medical marijuana law by stipulating that firefighters, emergency medical technicians, cardiac rescue technicians and paramedics employed by the state or local governments will not face employment discrimination or retaliation for testing positive for cannabis metabolites if they're a registered patient.

The governor of California has signed a bill to revise packaging and labeling rules for marijuana-infused edibles and beverages. Under AB 2532, which Gov. Gavin Newsom (D) approved on Wednesday, labels and inserts for cannabis edibles and drinks would need to include the toll-free telephone number for the national Poison Help line. The legislation from Assemblymember Jacqui Irwin (D) also mandates that labels for multi-serving THC beverages with more than one serving will need to "clearly and conspicuously" notify consumers that the product contains multiple servings as well as detail the size of servings—measured in fluid ounces to the nearest tenth of a fluid ounce—and provide "information regarding how to accurately measure a single serving for consumption."

Georgia regulators have approved new regulations that will allow medical marijuana to be delivered directly to patients—including via the U.S. Postal Service (USPS) and private carriers like FedEx, UPS and DHL. It's not clear, however, if those entities are willing to participate in cannabis commerce. The Georgia Access to Medical Cannabis Commission (GMCC) adopted the reform on Wednesday as part of a broader package of new rules covering issues such as product recalls, tracking, business license applications and research. The most notable change, on delivery via the mail, is being made possible by the Trump administration's move to reclassify medical cannabis, which effectively federally legalizes it, state officials have said.

A group of Republican senators are pressing the attorney general to "investigate the growing role of Chinese transnational criminal organizations in America’s cannabis and intoxicating-hemp markets." The lawmakers, led by Sen. Tom Cotton (R-AR), sent a letter to Attorney General Todd Blanche on Wednesday expressing concerns that criminal networks linked to China are "exploiting vulnerabilities in federal law to operate expansive illicit drug enterprises that threaten our communities and national security." Citing a Drug Enforcement Administration (DEA) report that found that Chinese criminal organizations "dominate marijuana cultivation and distribution in the United States, especially in states with legal cannabis markets," the GOP senators are asking the Department of Justice to "fully investigate these criminal networks, including their financing, land usage, chemical imports, and any connections to the Chinese Communist Party."

A new report from a bipartisan psychedelics caucus in Congress summarizes stakeholders' views on how the therapeutic use of substances like psilocybin, ibogaine and DMT can be "safely and ethically integrated" into the U.S. healthcare system, emphasizing the need for collaboration across federal agencies and with states. The document, published on Thursday by the Congressional Psychedelics Advancing Therapies (PATH) Caucus, comes after lawmakers in 2024 issued a request for information (RFI) seeking input from experts about how to best set up a regulatory framework for psychedelic medicines. An analysis of responses to the RFI found "broad consensus among clinicians, researchers, veteran advocates, Tribal leaders, payors, regulators, and patients that could offer safe, equitable, and evidence‑based treatment for a wide array of treatment-resistant conditions," a press release from the caucus says about the new report.

PA won't legalize marijuana soon, top GOP senator says; Ads against MA anti-cannabis ballot measure; VA psychedelics research op-ed Subscribe to receive Marijuana Moment’s newsletter in your inbox every weekday morning. It’s the best way to make sure you know which cannabis stories are shaping the day. Your support makes Marijuana Moment possible… Subscribers who value this daily dispatch enough to show their support with a few dollars help us keep doing this. Please chip in and help ensure Marijuana Moment's continued operations. / TOP THINGS TO KNOW Rep. Mike Lawler (R-NY), whose reelection campaign is being boosted with ads paid for by marijuana industry donations to a Trump-linked political action committee…

"People seeking healing should not have to live in fear of unnecessary criminalization." By Jack Gorsline, Psychedelic State(s) of America In a unanimous decision, the Portland, Oregon City Council voted on Wednesday to officially deprioritize law enforcement activities surrounding the personal use, cultivation and non-commercial sharing of naturally occurring psychedelics. The newly-passed ordinance carefully distinguishes between different types of substances and activities, designating non-commercial, naturally occurring psychedelics—including psilocybin mushrooms and ayahuasca—as low-priority targets for the Portland Police Bureau. However, the council included deliberate caveats in the policy. Peyote, a cactus containing the psychoactive compound mescaline, is explicitly excluded from the deprioritization measure.

"Independent psychedelic science is neither a rival nor a replacement for VA’s efforts. It is a necessary complement, one that can ask different questions, test different models of care and help reach veterans who might otherwise have nowhere else to turn." By Stacey Armstrong and Alan Davis, Ohio State University Center for Psychedelic Drug Research and Education When the Department of Veterans Affairs (VA) announced a major new psilocybin research initiative this summer, it signaled a remarkable shift in how America approaches veterans’ mental health. But if we want to understand whether psychedelic therapies can truly help veterans with post-traumatic stress disorder (PTSD), VA cannot do this work alone.

A Pennsylvania Democrats step up the push to legalize marijuana, the state's top Republican senator says he doesn't think the state will enact the policy change this year—and he believes that it should not move ahead at all without further changes at the federal level. "I don't see it coming before this session ends," Senate Majority Leader Joe Pittman (R) said when asked about the prospects of cannabis legalization at a press conference on Monday. "People tend to forget that recreational marijuana, for better or worse, is a scheduled narcotic at the federal level," he said.

A Massachusetts campaign working to keep recreational marijuana dispensaries open by defeating an initiative on the November ballot that would roll back the state's legalization law has launched two new ads. One spot rolled out on Tuesday by the No on 8: Stop the Repeal Campaign features Alan Balsam, a former commissioner of public health for the city of Brookline. "Not long ago, people in Massachusetts could only buy marijuana illegally. Question eight would take us back to those days," he said in the ad. "It bans the safe, legal sale of marijuana."

A Republican congressman whose reelection bid is being boosted by donations from some of the U.S.'s largest marijuana businesses says the legalization of cannabis is "hurting" society. A question posed to Rep. Mike Lawler (R-NY) and his Democratic opponent Cait Conely during a debate on Monday asked whether New York's legal cannabis law is "helping or hurting our local economy and neighborhoods." Conley said legal marijuana is "helping," while Lawler replied that it is "hurting." Although the answer is in line with the incumbent congressman's track record of opposing marijuana reform, it comes as his effort to keep his seat is being boosted with ads that are paid for by cannabis company contributions.

MA anti-marijuana measure poll; PA medical cannabis in hospitals; MD vets' cannabis law; Medical marijuana patient growth; Local psychedelics votes Subscribe to receive Marijuana Moment’s newsletter in your inbox every weekday morning. It’s the best way to make sure you know which cannabis stories are shaping the day. Your support makes Marijuana Moment possible… Before you dig into today's cannabis news, I wanted you to know you can keep this resource free and published daily by subscribing to Marijuana Moment on Patreon. We're a small independent publication diving deep into the cannabis world and rely on readers like you to keep going.

A Drug Enforcement Administration (DEA) judge is pausing proceedings in an ongoing hearing on the Trump administration's marijuana rescheduling proposal and asking asking agency officials and other participants to weigh in after a federal watchdog issued a report finding that there are "gaps" in the government's process for evaluating controlled substances. DEA Chief Administrative Law Judge Derek Julius on Tuesday issued a stay in response to a motion from a drug testing industry association and other participants who want a recent Government Accountability Office (GAO) report on drug scheduling to be entered into the record for the hearing, which took testimony in June and July.

"We all are very well aware that it was because we were unionizing." By Rebecca Rivas, Missouri Independent Madison Taylor has spent the past eight days picketing outside her former workplace, Greenlight Dispensary in Springfield. Two weeks ago, Taylor says she and a group of coworkers met outside of work to discuss forming a union. Days later, 12 employees who attended the meeting were fired, she said, after management accused them of consuming marijuana at work. The workers contend the firings were retaliation for their union activity. “My hope, at this moment, is to just continue speaking up for my coworkers’ rights, the industry workers as a whole, and making sure that our community continues to be aware of the predatory practices of this business,” Taylor told The Independent.

“As a police chief of any community, it's really important to understand the values of that community... This is something that we want to be on the forefront of.” By Jack Gorsline, Psychedelic State(s) of America The momentum for local psychedelics reform has continued to accelerate into the fall. On September 2, the Pierce County Council in Washington State voted unanimously to pass Resolution R2026-177, throwing its support behind continued research into entheogens and alternative treatment modalities. The passed resolution formally designates entheogen-related activities to be among the county’s lowest law enforcement priorities when no other suspected law violations are present.

There are nearly 4 million patients registered to use medical marijuana under state laws in the U.S., as well as at least 35,000 doctors and clinicians approved to recommend it and nearly 110,000 caregivers authorized to assist patients in growing and obtaining cannabis products, according to a pair of new studies. The number of Americans who are registered under state medical marijuana programs more than quintupled from about 747,000 in 2016 to approximately 3.9 million in 2024—though patient registration has "flattened since 2022, likely influenced by the growing number of jurisdictions with recreational cannabis laws," one of the papers published in the Annals of Internal Medicine said.

A Pennsylvania Senate committee has approved a bill to allow terminally ill patients to use medical cannabis in hospitals and other healthcare facilities. The Senate Law & Justice Committee advanced the legislation from Sen. John Kane (D) in a unanimous vote on Tuesday, months after a similar proposal was passed by the full House of Representatives. As approved by the Senate panel, SB 1035 would allow patients who have a prognosis of less than a year left to live to use medical marijuana in hospitals, long-term care nursing homes, hospices and other facilities.

The latest in a series of polls ahead of the November elections continues to show that a sizable majority Massachusetts voters oppose a measure on the ballot that would roll back the state's marijuana legalization law. The new survey, published on Tuesday by CommonWealth Beacon and conducted by MassINC Polling Group (MPG), shows that 61 percent of likely voters oppose the initiative—which would repeal laws allowing the regulated commercial sales of recreational cannabis and home cultivation while maintaining legal possession and continuing the medical marijuana system. Just 27 percent of respondents said they favor the anti-cannabis ballot measure, while 11 percent are undecided and 1 percent responded that they would prefer not to state their opinion.

A new Maryland law that provides legal protections for veterinarians who recommend medical marijuana for animals will take effect on Thursday. The legislation, which was passed by lawmakers and signed by Gov. Wes Moore (D) will make it so the State Board of Veterinary Medical Examiners cannot "suspend or revoke a license, reprimand or censure a licensee, or place a licensee on probation solely on the basis of the licensee discussing or recommending the use of cannabis...or a product that contains cannabidiol on an animal for potential therapeutic effect or health supplementation purposes."

Marijuana breathalyzers' link to bomb detection tech; PA hemp regulation bill; Study: Medical cannabis use by cancer patients Subscribe to receive Marijuana Moment’s newsletter in your inbox every weekday morning. It’s the best way to make sure you know which cannabis stories are shaping the day. Your support makes Marijuana Moment possible… BREAKING: Journalism is often consumed for free, but costs money to produce! While this newsletter is proudly sent without cost to you, our ability to send it each day depends on the financial support of readers who can afford to give it.

Medical marijuana is "commonly" used to treat symptoms of cancer such as pain, nausea, anxiety, depression, poor appetite and sleep disturbance, according to a new study—and 80 percent of patients report that it provides relief and improved quality of life. The study, conducted by researchers at the University of Kentucky, surveyed 237 adults receiving radiation therapy for cancer at either an urban or a rural oncology practice in Kentucky, which is described in the paper as "a unique geographical area with high endemic use of narcotics." About half of the patients (51 percent) reported they had used marijuana at least once in their lifetimes, with the researchers saying that "self-administration of unprescribed medicinal cannabis use was common across demographic groups and was primarily directed toward symptom management."

“If Black Virginians only make up 19 percent, how is it that they are 47.7 percent of those who are receiving the citations?” By Markus Schmidt, Virginia Mercury Youth advocates are urging Virginia lawmakers to reconsider stiffer penalties for public marijuana use before the state opens its legal adult-use market next summer, warning that the changes could place a disproportionate burden on young people, their families and Black communities. The maximum civil penalty for consuming or offering marijuana in public is set to rise from $25 to $250 on July 1, 2027, the same day retail sales are scheduled to begin.

A Pennsylvania Republican senator is asking colleagues to support a forthcoming bill she plans to introduce to keep hemp THC products legal in the state while adding age limits as well as new requirements for registration, testing and labeling. Sen. Dawn Keefer (R) announced the Pennsylvania Hemp and Cannabinoid Act in a cosponsorship memo on Friday. "The bill gives responsible hemp businesses a clear state framework and keeps intoxicating products out of the hands of children while federal hemp policy remains unsettled," she wrote. While federal hemp policy remains in flux, there is no statewide system for consumable hemp products—with "no Pennsylvania age gate, no uniform testing or labeling standard, and no retail accountability," the senator said.

California's governor has signed a pair of bills revising various state marijuana laws related to product testing, tracking, consumer access to information and cannabinoid content. Gov. Gavin Newsom (D) on Sunday gave final approval to AB 1965 from Assemblymember LaShae Sharp-Collins (D), which would specify that all marijuana products for sale in the state are subject to testing or retesting and allow the Department of Cannabis Control (DCC) to obtain products for off-the-shelf laboratory testing. The new law also mandates that cannabis retailers are required to provide a product's certificate of analysis if requested by a consumer.

A federal agency is highlighting how a technique that was created to capture specific compounds from air samples for analysis to help detect bombs after 9/11 is now being used to aid in the development of a marijuana breathalyzer to identify impaired drivers. The National Institute of Standards and Technology (NIST) cited the cannabis technology effort as part of a new post on how scientific discoveries often have unexpected applications. "Painter Bob Ross taught us that 'happy accidents' can make for beautiful art," the agency said. "Happy accidents also happen in science, when experiments take research in unexpected directions.

Campaign ad highlights senator's anti-marijuana stance; Poll: MA voters oppose legalization rollback; State cannabis officials want DEA cooperation Subscribe to receive Marijuana Moment’s newsletter in your inbox every weekday morning. It’s the best way to make sure you know which cannabis stories are shaping the day. Your support makes Marijuana Moment possible… Your good deed for the day: donate to an independent publisher like Marijuana Moment and ensure that as many voters as possible have access to the most in-depth cannabis reporting out there. Support our work at / TOP THINGS TO KNOW…

"The consumer demand in North Carolina is clear, and the passing of this near-total ban bill would take good actors like us out of this space and allow bad actors to flourish." By Melissa Johnston, Tryon Distributing via Carolina Journal North Carolina holds an immense opportunity to create the best hemp beverage law in the county, and I would like to see us take advantage of it. In August, the General Assembly decided to table the hearing of HB 328—a bill that would have cemented an all but total ban on all hemp beverages…

“This was an industry fighting for its survival, and it really came together. This is a profound thing.”  By Jake Thomas, Oregon Capital Chronicle State regulators have backed off pursuing sizable fee increases on Oregon’s magic mushroom businesses after dire warnings from the legal psilocybin industry that it would buckle under the added costs. The Oregon Health Authority announced Tuesday that it would not adopt proposed rules that would have doubled the annual licensing fees for businesses across the psilocybin supply chain while eliminating discounts for veterans and low-income people.

Pennsylvania is poised to legalize marijuana as soon as next year if Democrats can win a handful of key state legislative races in the November elections, a top lawmaker says. House Speaker Joanna McClinton (D) said at a Black Cannabis Week event on Friday that the state still has "a ways to go" to catch up with its neighbors that have already "moved in the right direction" by enacting marijuana legalization. While McClinton's chamber passed a bill to legalize cannabis last year, it has stalled in the Senate, where Republican have a narrow majority.